Wealth-related inequalities of women's knowledge of cervical cancer screening and service utilisation in 18 resource-constrained countries: evidence from a pooled decomposition analysis.
Cervical cancer screening services
Decomposition analyses
Knowledge
Resource-constrained countries
Utilisation
Journal
International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692
Informations de publication
Date de publication:
26 03 2020
26 03 2020
Historique:
received:
11
12
2019
accepted:
09
03
2020
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
11
11
2020
Statut:
epublish
Résumé
Resource-constrained countries (RCCs) have the highest burden of cervical cancer (CC) in the world. Nonetheless, although CC can be prevented through screening for precancerous lesions, only a small proportion of women utilise screening services in RCCs. The objective of this study was to examine the magnitude of inequalities of women's knowledge and utilisation of cervical cancer screening (CCS) services in RCCs. A total of 1,802,413 sample observations from 18 RCC's latest national-level Demographic and Health Surveys (2008 to 2017-18) were analysed to assess wealth-related inequalities in terms of women's knowledge and utilisation of CCS services. Regression-based decomposition analyses were applied in order to compute the contribution to the inequality disparities of the explanatory variables for women's knowledge and utilisation of CCS services. Overall, approximately 37% of women had knowledge regarding CCS services, of which, 25% belonged to the poorest quintile and approximately 49% from the richest. Twenty-nine percent of women utilised CCS services, ranging from 11% in Tajikistan, 15% in Cote d'Ivoire, 17% in Tanzania, 19% in Zimbabwe and 20% in Kenya to 96% in Colombia. Decomposition analyses determined that factors that reduced inequalities in women's knowledge of CCS services were male-headed households (- 2.24%; 95% CI: - 3.10%, - 1.59%; P < 0.01), currently experiencing amenorrhea (- 1.37%; 95% CI: - 2.37%, - 1.05%; P < 0.05), having no problems accessing medical assistance (- 10.00%; 95% CI: - 12.65%, - 4.89%; P < 0.05), being insured (- 6.94%; 95% CI: - 9.58%, - 4.29%; P < 0.01) and having an urban place of residence (- 9.76%; 95% CI: - 12.59%, - 5.69%; P < 0.01). Similarly, factors that diminished inequality in the utilisation of CCS services were being married (- 8.23%;95% CI: - 12.46%, - 5.80%; P < 0.01), being unemployed (- 14.16%; 95% CI: - 19.23%, - 8.47%; P < 0.01) and living in urban communities (- 9.76%; 95% CI: - 15.62%, - 5.80%; P < 0.01). Women's knowledge and utilisation of CCS services in RCCs are unequally distributed. Significant inequalities were identified among socioeconomically deprived women in the majority of countries. There is an urgent need for culturally appropriate community-based awareness and access programs to improve the uptake of CCS services in RCCs.
Identifiants
pubmed: 32216799
doi: 10.1186/s12939-020-01159-7
pii: 10.1186/s12939-020-01159-7
pmc: PMC7098106
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
42Références
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
pubmed: 15734974
PLoS One. 2012;7(11):e48834
pubmed: 23155413
Int J Health Serv. 2011;41(3):483-99
pubmed: 21842574
Prev Med. 2019 Mar;120:60-70
pubmed: 30659908
BMC Public Health. 2019 Apr 24;19(1):428
pubmed: 31014308
J Prev Med Public Health. 2017 Jan;50(1):18-28
pubmed: 28173687
J Womens Health (Larchmt). 2017 May;26(5):403-412
pubmed: 28513340
BMC Womens Health. 2019 Aug 9;19(1):108
pubmed: 31399092
J Womens Health (Larchmt). 2007 Jan-Feb;16(1):36-45
pubmed: 17324095
Eur J Cancer. 2013 Oct;49(15):3262-73
pubmed: 23751569
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Womens Health. 2019 Jul 03;11:381-386
pubmed: 31308762
Soc Sci Med. 2018 Jan;197:203-212
pubmed: 29253722
J Community Health. 2019 Jun;44(3):492-499
pubmed: 30989454
J Prof Nurs. 2005 Jul-Aug;21(4):216-22
pubmed: 16061168
Reprod Health Matters. 2008 Nov;16(32):41-9
pubmed: 19027621
Niger J Clin Pract. 2006 Jun;9(1):40-3
pubmed: 16986288
Bull World Health Organ. 2017 Jan 1;95(1):76-78
pubmed: 28053367
Glob Health Promot. 2019 Sep;26(3):50-61
pubmed: 28944716
Cancer Causes Control. 2009 May;20(4):449-57
pubmed: 19082746
Int J Equity Health. 2018 Dec 13;17(1):184
pubmed: 30545425
Prev Med. 2019 Jun;123:55-64
pubmed: 30796926
J Glob Oncol. 2017 Mar 17;3(5):611-634
pubmed: 29094100
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
Int J Cancer. 2009 Apr 1;124(7):1626-36
pubmed: 19115209
Int J Public Health. 2011 Apr;56(2):139-52
pubmed: 21327854
Pan Afr Med J. 2015 Jul 30;21:231
pubmed: 26523173
Int J Gynecol Cancer. 2003 Nov-Dec;13(6):827-33
pubmed: 14675320
Cancer Causes Control. 2001 Aug;12(6):519-28
pubmed: 11519760
Afr Health Sci. 2010 Mar;10(1):89-92
pubmed: 20811531
BMC Womens Health. 2016 Jun 04;16:29
pubmed: 27259656
Br J Cancer. 1995 Aug;72(2):498-505
pubmed: 7640239
Int J Equity Health. 2016 Feb 24;15:30
pubmed: 26912345
Ann Oncol. 2006 Jun;17 Suppl 8:viii9-viii14
pubmed: 16801342
PLoS Med. 2008 Jun 17;5(6):e132
pubmed: 18563963
Lancet Oncol. 2011 Mar;12(3):306-12
pubmed: 21376292
Int J Epidemiol. 2010 Jun;39(3):757-65
pubmed: 20176587
BMC Public Health. 2019 Apr 25;19(1):434
pubmed: 31023306
Med Princ Pract. 2013;22(4):313-22
pubmed: 23328247
PLoS One. 2016 Sep 30;11(9):e0163136
pubmed: 27690311
BMJ Open. 2017 Jun 11;7(6):e016282
pubmed: 28606908
BMC Med. 2012 Nov 13;10:136
pubmed: 23146319
J Obstet Gynaecol. 2020 Apr;40(3):395-400
pubmed: 32091288
BMC Womens Health. 2019 Jul 8;19(1):91
pubmed: 31286937
PLoS One. 2012;7(4):e35469
pubmed: 22530028
Trop Med Infect Dis. 2018 Jun 25;3(3):
pubmed: 30274468